Amgen announces final results of tender offer
Amgen announced the final results of its modified Dutch auction tender offer, which expired March 5, 2018. Amgen has accepted for purchase 52,083,333 shares of its common stock, $0.0001 par value per share, at a price of $192 per share, for an aggregate cost of approximately $10 billion. March 08, 2018